Laboratory Ownership
| LH Stock | USD 198.40 0.05 0.03% |
Shares in Circulation | First Issued 1988-03-31 | Previous Quarter 84.9 M | Current Value 84.7 M | Avarage Shares Outstanding 88.1 M | Quarterly Volatility 36.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Laboratory |
Laboratory Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The book value of Laboratory was now reported as 93.86. The company has Price/Earnings To Growth (PEG) ratio of 0.48. Laboratory last dividend was issued on the 28th of May 2024. The entity had 1164:1000 split on the 3rd of July 2023. Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina. Laboratory Corp operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 75000 people. To find out more about Laboratory of contact Deborah Tanner at 336 229 1127 or learn more at https://www.labcorp.com.Besides selling stocks to institutional investors, Laboratory also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Laboratory's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Laboratory's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Laboratory Quarterly Liabilities And Stockholders Equity |
|
Laboratory Insider Trades History
Less than 1% of Laboratory of are currently held by insiders. Unlike Laboratory's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Laboratory's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Laboratory's insider trades
Laboratory Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Laboratory is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Laboratory of backward and forwards among themselves. Laboratory's institutional investor refers to the entity that pools money to purchase Laboratory's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Norges Bank | 2023-12-31 | 1.3 M | Bank Of America Corp | 2023-12-31 | 1.3 M | Ubs Asset Mgmt Americas Inc | 2023-12-31 | 1.2 M | Northern Trust Corp | 2023-12-31 | 1.2 M | Veritas Investment Partners (uk) Ltd. | 2023-12-31 | 1.1 M | Amvescap Plc. | 0031-12-31 | 1.1 M | Fmr Inc | 2023-12-31 | 1.1 M | Allspring Global Investments Holdings, Llc | 2023-12-31 | 1 M | Nuveen Asset Management, Llc | 2023-12-31 | 920.5 K | Blackrock Inc | 2023-12-31 | 10.5 M | Vanguard Group Inc | 2023-12-31 | 9.7 M |
Laboratory Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Laboratory insiders, such as employees or executives, is commonly permitted as long as it does not rely on Laboratory's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Laboratory insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Peter Wilkinson over two months ago Payment of tradable shares by Peter Wilkinson of Laboratory subject to Rule 16b-3 | ||
Peter Wilkinson over two months ago Exercise or conversion by Peter Wilkinson of 131 shares of Laboratory subject to Rule 16b-3 | ||
Peter Wilkinson over three months ago Sale by Peter Wilkinson of 1384 shares of Laboratory | ||
Peter Wilkinson over a year ago Payment of tradable shares by Peter Wilkinson of Laboratory subject to Rule 16b-3 |
Laboratory Outstanding Bonds
Laboratory issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Laboratory uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Laboratory bonds can be classified according to their maturity, which is the date when Laboratory of has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| LABORATORY P AMER Corp BondUS50540RAS13 | View | |
| LABORATORY P AMER Corp BondUS50540RAT95 | View | |
| LABORATORY P AMER Corp BondUS50540RAQ56 | View | |
| US50540RAW25 Corp BondUS50540RAW25 | View | |
| LH 155 01 JUN 26 Corp BondUS50540RAX08 | View | |
| LABORATORY P AMER Corp BondUS50540RAU68 | View | |
| US50540RAV42 Corp BondUS50540RAV42 | View | |
| LH 27 01 JUN 31 Corp BondUS50540RAY80 | View |
Laboratory Corporate Filings
8K | 25th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 17th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 4th of April 2024 Other Reports | ViewVerify | |
10K | 26th of February 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.46) | Dividend Share 2.88 | Earnings Share 4.33 | Revenue Per Share 139.628 | Quarterly Revenue Growth 0.035 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.